DAILY CURRENT AFFAIRS: 25th MARCH 2020: THE HINDU + PIB

Daily Current Affairs: 25th March 2020: The Hindu+PIB

The following compilation has been made keeping in mind the need of the UPSC IAS exam. Each and every topic which has been included in this compilation is taken from very authentic and relevant source including The HinduThe Indian ExpressBusiness Standard, Press Information Bureau, etc.

As per the evolving pattern of the UPSC IAS prelims and mains exam each and every topic has been handpicked keeping in mind the syllabus of the exam.


Table of Contents

    MPLADS FUNDS TO BE UTILIZED FOR COVID-19

    Context: As a part of Government’s efforts to contain spread of COVID – 19, the Ministry of Statistics and Programme Implementation (MoSPI) has issued a circular granting one-time dispensation for utilizing funds under the Members of Parliament Local Area Development Scheme (MPLADS).


    MPLAD SCHEME

    HOW IT WILL HELP?


    This move is going to facilitate Members of Parliament to recommend funds for purchase of equipments for Government Hospitals / Dispensaries for medical testing and screening of patients and also facilitate in setting up other related facilities in their respective constituencies.

    WHAT ARE THE CATEGORIES WHERE MPLADS FUNDS CAN BE UTILIZED?

    As per the amendments to MPLADS Guidelines, Members of Parliament can now utilize funds under MPLADS for the following:-

    • Infra-Red thermometers (Non-contact) to enable doctors and medical personnel to record and track a person’s temperature.
    • Personal Protection Equipment (PPE) Kits to keep the medical personnel well-protected and enable them to function efficiently by minimizing the risk of transmission.
    • Thermal imaging scanners or cameras for railway stations, airports and other points of entry which allow detecting of temperature from a safe distance.
    • CORONA testing kits approved by M/o Health and Family Welfare
    • ICU Ventilator and Isolation/ Quarantine Wards within their approved facilities.
    • Face masks, gloves and Sanitizers for medical personnel.
    • Any other medical equipment recommended by Ministry of Health and Family Welfare for prevention, control and treatment of COVID-19.

    ABOUT MPLAD SCHEME

    The Local Area Development Scheme known as MPLADS is a government scheme that was launched on 23rd December 1993. This central sector scheme was developed as an initiative to enable the parliament members to recommend developmental work in their constituencies based on locally felt needs. These developmental works mainly focused on the areas of national priorities such as drinking water, education, public health, sanitation, roads, etc. 


    Members of Parliament Local Area Development Scheme (MPLADS) was launched by PM Narendra Modi under the Ministry of Statistics and Programme Implementation. This scheme was initially administered by the Ministry of Rural Development.


    KEY FEATURES OF MPLADS


    Some of the key features of the Members of Parliament Local Area Development Scheme (MPLADS) are:

    • It is a government-funded scheme where the annual fund provided to each MP constituency is Rs. 5 crores.
    • Recommendation by the MPs should be done annually with works costing at least 15 per cent of the MPLADS entitlement for areas inhabited by Scheduled Caste population and 7.5 per cent for areas inhabited by S.T. population
    • A sum of Rs. 75 lakhs is provided for building assets by trusts and societies as per the scheme guidelines to encourage the trusts and societies for the betterment of tribal people.
    • Lok Sabha Members can recommend works within their Constituencies and Elected Members of Rajya Sabha can recommend works within the State of Election. Nominated Members of both the Rajya Sabha and Lok Sabha can recommend works anywhere in the country.

    IMPLEMENTATION OF MPLAD SCHEME
    • An MP is required to provide his/her choice of the nodal district to the Ministry of Statistics and Programme Implementation in a prescribed format. A copy of the same should be given to the State Government and the District Magistrate of the chosen district. 
    • The Government of India releases an annual entitlement of Rs. 5 crores in two equal instalments. This amount is given to the District Authority of the Nodal District selected by the concerned MP.

    • The Implementing Agency should be identified by the District Authority. The Implementing Agency should have the capability to execute the eligible work qualitatively, timely and satisfactorily. 

    • All the recommended works must be sanctioned within 75 days from the date of receipt of the recommendation after the completion of all formalities. If any work is not sanctioned within the prescribed time period, the District Authority shall, however, may inform the MPs regarding the rejection of the work within 45 days from the date of receipt of recommendations.

    • This scheme can also be converted into individual/stand-alone projects under the Central and State Government schemes provided they meet the eligibility conditions of MPLADS

    • Funds from local bodies can be similarly pooled with MPLADS works but the funds provided by other scheme sources should be used first. MPLADS funds should be released later for the successful completion of the project. As soon as a work under the Scheme is completed, it should be put to public use. 

    Also Read: ULTIMATE GUIDE TO WRITE AN EFFECTIVE ESSAY IN UPSC IAS MAINS

    INVEST INDIA BUSINESS IMMUNITY PLATFORM


    Context: While COVID-19  continues to disrupt normal life, the impact of this crisis on businesses across the country is being continuously assessed. The government, for its part, has issued timely guidelines for businesses. As part of the guidelines, The Invest India Business Immunity Platform has also been launched.


    BUSINESS IMMUNITY PLATFORM





    ABOUT INVEST INDIA BUSINESS IMMUNITY PLATFORM


    The Invest India Business Immunity Platform has been launched by Invest India, India’s national Investment Promotion & Facilitation Agency, under the Ministry of Commerce and Industry.  The platform, hosted on the Invest India website, is designed as a comprehensive resource to help businesses and investors get real-time updates on India’s active response to COVID-19 (Coronavirus)


    HOW THIS PLATFORM IS GOING TO HELP?


    This dynamic and constantly updating platform keeps a regular track on developments with respect to the virus, provides latest information on various central and state government initiatives, gives access to special provisions, and answers and resolves queries through emails and on WhatsApp


    The Business Immunity Platform (BIP) is the active platform for business issue redressal, operating 24/7, with a team of dedicated sector experts and responding to queries at the earliest. 


    Invest India has also announced a partnership with SIDBI (Small Industries Development Bank of India) for responding and resolving queries for MSMEs


    The platform also includes frequently asked questions (FAQs) on important aspects like locations of COVID-19 testing, special permissions and other location-specific information. The portal also maps and highlights the response mechanism put in place by leading Indian companies such as: 

    • Sanitation of staff vehicles, 
    • Placing orders in alternate markets, 
    • Disabling biometric attendance systems, 
    • Setting up of medical task force, 
    • Requesting trainees to go home, 
    • Business continuity plan, 
    • Barring entry of visitors, 
    • Suspension of air travel, 
    • Usage of video-conferencing and tele-conferencing, 
    • Developing online solutions and other unique initiatives.

    This Business Immunity Platform shall help people get access to all the information they require while staying in their comfort of their homes. With this platform, Invest India aims to bring facilitation at your doorstep!


    ABOUT INVEST INDIA


    Invest India, set up in 2009, is a non-profit venture under the Department for Promotion of Industry and Internal Trade, Ministry of Commerce and Industry, Government of India.


    As the national investment promotion and facilitation agency, Invest India focuses on sector-specific investor targeting and development of new partnerships to enable sustainable investments in India. In addition to a core team that focuses on sustainable investments, Invest India also partners with substantial investment promotion agencies and multilateral organizations. 


    Invest India also actively works with several Indian states to build capacity as well as bring in global best practices in investment targeting, promotion and facilitation areas.


    (adsbygoogle = window.adsbygoogle || []).push({});

    DIAGNOSTIC KIT FOR COVID-19 BY CCMB


    Context: Centre for Cellular and Molecular Biology (CCMB) is working overtime on the development of cost-effective and accurate diagnostic kits for COVID-19.


    CORONAVIRUS DIAGNOSTIC KIT



    The kit is being developed following the World Health Organization call for “testing, testing and testing” as the key to combat COVID-19 and save as many lives as possible via early diagnostic.


    WHAT ARE THE STEPS BEING TAKEN?



    Centre for Cellular and Molecular Biology (CCMB) is keeping in mind the cost and are planning to keep it within the range of Rs 400-500. Further,  CCMB is also planning to culture the covid-19 virus


    There are 5 government designated testing centres in Telangana state. CCMB has trained 25 people so that they can go and do the testing in these centres.


    Some of the labs where the COVID-19 testing will be done include Nizam’s Institute Of Medical Sciences (NIMS) Hydrabad, Gandhi Hospital, Osmania General Hospital, Sir Ronald Ross Institute of Tropical and Communicable Diseases or the Fever Hospital and the Warangal Hospital. The Centre for DNA Finger Printing and Diagnostics (CDFD) is also likely to be added to this group.


    Vaccine and drug development are another aspect of fighting the virus. But as of now CCMB is neither working on the vaccine nor on the drug development. There is a possibility that may be CCMB’s sister organisation Indian Institute of Chemical Technology (IICT) is working for repurposing of drugs as making a new drug is a long-term process. 


    ABOUT CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY (CCMB)



    The Centre for Cellular and Molecular Biology (CCMB) is an Indian biotechnology research establishment located in Hyderabad that operates under the aegis of the Council of Scientific and Industrial Research (CSIR)


    CCMB is a designated “Center of Excellence” by the Global Molecular and Cell Biology Network, UNESCO. The Republic of India’s national biosafety level – 4 containment facility for human infectious diseases is located on the campus of CCMB. 



    The center collaborates with the University of Nebraska Medical Center for translational research on glaucoma. In addition, the centre receives funding for specific collaborative projects from establishments outside India, such as:

    • National Institutes of Health, Harvard Medical School and the Massachusetts Institute of Technology in the United States. 
    • The Imperial Cancer Research Fund and Cambridge University in the United Kingdom. 
    • The India-Japan Science Council and the University of Ryukyus in Japan.
    • Centre Nationale de la Recherche Scientifique and the Pasteur Institute in France. 
    • The Volkswagen Foundation in Germany.

    TECHNOLOGICAL ACHIEVEMENTS OF CCMB


    • Discovered the heart disease mutation, carried by sixty million people among Indians. 
    • Developed the first genetically engineered, gene knockout mouse in India. 
    • Developed the first artificial insemination technology in India, to deliver extinct ruminant mammals, like deer. 
    • Developed a systematic screening and validation programme for anti-cancer drugs in India. 
    • Discovered the origin of Andaman tribes, through DNA Fingerprinting technology.
    • Commercially delivered, recombinant DNA technology based diagnostic kit for detection of pathogens causing ophthalmic infections. 
    • Discovered high yielding disease resistant rice
    • Discovered native bacteria, Indibacter alkaliphilus used to generate Enzymes and Bio-molecules in the Industrial Biotechnology sector. 
    • Discovered the functionality of micro-satellites (simple sequence repeats) among non-coding DNA. 
    • Discovered the gene CPA1, which causes chronic pancreatitis, in collaboration with Asian Institute of Gastroenterology.
    • The ongoing research programmes at the CCMB are in three major categories(i) High quality basic research in the frontier areas of modern biology, (ii) Research relevant to societal needs, and (iii) Application-oriented research towards commercialisation. 

    WAYANAND WILDLIFE SANCTUARY


    Context: Wayanad Wildlife Sanctuary, though home to more than half the number of tigers present in Kerala, may not be notified as a Tiger Reserve as it lacks public support.


    WAYANAD TIGER RESERVE



    BACKGROUND


    The Status of Tigers in India report released last year had estimated the tiger population of Wayanad as between 75 and 80 individuals. Periyar Tiger Reserve, the first one in Kerala, has an estimated population of 30 to 35 big cats whereas Parambikulam, the second reserve, has a population of 20 to 25 tigers.

    Cattle lifting by the ailing tigers and their straying into human habitations  have often triggered widespread public protests in the district. The department had to backtrack from its earlier attempts to notify the reserve following stiff public resistance. There were speculations that the notification would bring in stringent restrictions on development activities.

    ABOUT WAYANAD WILDLIFE SANCTUARY
    • LOCATION: Kerala, India.
    • ESTABLISHED: 1973
    • EXTENT: 344.44 km2 with four ranges namely Sulthan Bathery, Muthanga, Kurichiat and Tholpetty.
    • BORDERS: It is an integral part of the Nilgiri Biosphere Reserve. It is bounded by protected area network of Nagarhole and Bandipur of Karnataka in the northeast, and on the southeast by Mudumalai of Tamil Nadu. It is part of the Deccan Plateau.
    • FLORA: Moist deciduous forest consists of maruthikarimaruthirosewoodventeakvengalchadachimazhukanjirambamboos, more, while the semi-evergreen patches comprises veteria indica., lagerstroemialanceolatatermianalia paniculata.
    • FAUNA: Elephantstigerspanthersjungle catscivet cats, monkeys, wild dogs, bisons, deer, bears, monitor lizards and a variety of snakes are seen.
      •  Apart from that, Peacocksbabblerscuckoosowlswoodpeckersjungle fowls are a few of the various types of birds seen here. Wayanad Wildlife Sanctuary is one of the safest havens for different species of vultures like the White-rumped Vultures and the Red-headed Vultures.
      • A monitoring programme of the Forest Department for 2017-18 has found that the Wayanad Wildlife Sanctuary (WWS), holds the largest tiger population in the State.
    • OTHERS: Wayanad district has the largest population of Adivasi in Kerala. Scheduled tribes here include PaniyasKurumasAdiyansKurichiyasOoralis and Kattunaikkans. This wildlife sanctuary comes under Protect Elephant.


    (adsbygoogle = window.adsbygoogle || []).push({});

    CENTRAL DRUGS STANDARD CONTROL ORGANIZATION (CDSCO) APPROVAL TO FIRST COVID-19 KIT



    Context: First Made in India Test Kit to diagnose COVID-19 has got the commercial approval by the Central Drugs Standard Control Organisation (CDSCO).


    Mylab PathoDetect COVID-19 Qualitative PCR kit



    ABOUT THE KIT 


    Pune-based molecular diagnostics company Mylab Discovery Solutions Pvt Ltd, which specialises in molecular diagnostic kits has developed first made-in-India test kit for COVID-19 in a record time of six weeks


    he kit — Mylab PathoDetect COVID-19 Qualitative PCR kit — is the first one to receive commercial approval from the Indian FDA/ Central Drugs Standard Control Organisation (CDSCO). 


    Besides, Mylab is the only Indian company to have achieved 100 per cent sensitivity and specificity in the ICMR evaluation. Mylab has several years of experience in manufacturing RTPCR kits. It manufactures a range of kits at the facility approved by Indian FDA/CDSCO and is compliant with MDR 2017 regulation for manufacturing medical devices of Class C and D, the most stringent and regulated products by the government. 


    Mylab currently manufactures ID-NAT screening kits for blood banks/hospitals, Quantitative HIV, HBV and HCV kits. Mylab has also received clearance from Drugs Controller General of India (DCGI) to manufacture the COVID-19 Qualitative kit, in the same facility. The Mylab COVID-19 kit had been evaluated at the Indian Council of Medical Research (ICMR).

    HOW THIS KIT WOULD BE BENEFICIAL?  


    Currently, India ranks lowest in terms of testing done per million population. The number is as low as 6.8. Countries like South Korea and Singapore have been able to contain the growing number of Coronavirus cases by enhancing the number of testing.


    So far, the Indian government has been sourcing millions of testing kits from Germany to facilitate testing to diagnose Coronavirus patients PAN-India. However, the dependency on foreign kits has been troublesome and supply is getting blocked due to grounded airlines. This can change with the approval for made in India kits.


    As claimed by the Mylabs, it can manufacture up to 1 lakh tests in a week that can be further scaled up if needed. Further, the company claims that its test kits can test about 100 patients with one kit. An average lab with automated PCR can test more than 1000 patients a day. With local sourcing of test kits, it will be a breakthrough for India as the testing kit by Mylab would cost nearly one-fourth of the current procurement cost


    Moreover, Mylab PathoDetect COVID-19 Qualitative PCR kit screens and detects the infection within 2.5 hours, compared to seven-plus hours taken by current protocols. This means that laboratories will be able to do twice the number of reactions at the same time on one machine.


    ABOUT CDSCO


    The Central Drugs Standard Control Organisation(CDSCO) under Directorate General of Health Services, Union Ministry of Health is the National Regulatory Authority (NRA) of India. Its headquarter in New DelhiUnder the Drugs & Cosmetics Act,1940, CDSCO is responsible for approval of Drugs, Conduct of Clinical Trials, laying down the standards for Drugs, control over the quality of imported Drugs in the country. 

    Also Read: ULTIMATE GUIDE TO UPSC IAS EXAM PREPARATION

    NATIONAL SUPERCOMPUTING MISSION

    Context: Information regarding the National Supercomputing Mission was provided by the Government of India to the Parliament.


    NATIONAL SUPERCOMPUTING MISSION





    ABOUT THE MISSION


    National Supercomputing Mission (NSM) of India was set up to meet the increasing computational demands of academia, researchers, MSMEs, and startups by creating the capability design, manufacturing, of supercomputers indigenously in India. The Mission is steered jointly by the Ministry of Electronics and IT (MeitY) and Department of Science and Technology (DST).

    The responsibility of the implementation of National Supercomputing Mission lies with the Centre for Development of Advanced Computing (C-DAC), Pune and the Indian Institute of Science (IISc), Bengaluru.


    TARGET 


    The main target of the mission was set to establish a network of supercomputers ranging from a few Tera Flops (TF) to Hundreds of Tera Flops (TF) and three systems with greater than or equal to 3 Peta Flops (PF) in academic and research institutions of National importance across the country by 2022.


    BACKGROUND 


    This network of Supercomputers envisaging a total of 15-20 PF was approved in 2015 and was later revised to a total of 45 PF (45000 TFs), a jump of 6 times more compute power within the same cost and capable of solving large and complex computational problems.


    The first supercomputer assembled indigenously, called Param Shivay, was installed in IIT (BHU) and was inaugurated by the Prime Minister. Similar systems Param Shakti and Param Brahma were installed at IIT-Kharagpur and IISER, Pune. They are equipped with applications from domains like Weather and Climate, Computational Fluid Dynamics, Bioinformatics, and Material science.


    FUTURE PLANS


    There are plans to install three more supercomputers by April 2020, one each at IIT-Kanpur, JN Centre for Advanced Scientific Research, Bengaluru, and IIT-Hyderabad. This will ramp up the supercomputing facility to 6 PF.


    Further, 11 new systems are likely to be set up in different IITs, NITs, National Labs, and IISERs across India by December this year, which will have many sub-systems manufactured and microprocessors designed in India which will bring in a cumulative capacity of 10.4 petaflops.



    Spreading out the reach to the North-East region of the country, 8 systems with a total Compute Power of 16 PF are being commissioned. 5 indigenously designed systems with three 3 PF computing power will be installed at IIT-Mumbai, IIT-Chennai and Inter-University Accelerator Centre (IUAC) at Delhi with NKN as its backbone


    It also includes an indigenously build 20 PF system at C-DAC, Pune, and a 100 PF Artificial Intelligence supercomputing system. One mid-level 650 TFs system is also to be installed at C-DAC Bengaluru to provide consultancy to Start-ups, SSIs & MSMEs.


      (adsbygoogle = window.adsbygoogle || []).push({});

      MADHYA PRADESH TOPS IN NEONATAL DEATHS


      Context: Madhya Pradesh has recorded the highest percentage of newborn  deaths of 11.5% against the total admissions to government-run Sick-Newborn Care Units (SNCUs) in the past 3 years across the country.


      NEONATAL DEATHS


      KEY INFORMATION

      • According to the National Health Mission (NHM), this rate of 11.5% in Madhya Pradesh is ominously spiralling since 2017. 
      • The country’s average for neo-natal deaths is just 7%.
      • Although admissions of neonates (under 28 days) in the State have dropped from April 2017 to December 2019 — remaining lower than West BengalRajasthan and Uttar Pradesh — the percentage of deaths at 12.2% surpassed Bihar’s last year.
      • Meanwhile, West Bengal, where 34,344 neonatal deaths occurred in the period, the most in the country, the declining percentage of deaths from 9.2% in 2017 to 8.9% in 2019 coincided with a slump in admissions.
      • Staff crunchlow community referrals, absence of a special neonatal transport service to health centres, and the non-availability of enough units to cater to increasing institutional deliveries had contributed to the spike in the percentage of deaths.
      • The crunch is magnified as only one against the requisite five (82% shortfall) of surgeonsgynaecologistsphysicians and paediatricians is available at hospitals.
      • Madhya Pradesh has also recorded an abysmal sex-ratio in admissions. Even with a sex ratio of 931 as per the 2011 census, 663 girls were admitted against 1,000 boys in the three years, against the country average of 733.
      • In Bhopal, the capital city of Madhya Pradesh, one in every five children admitted to a unit died in the three years — the highest death percentage of 19.9% in the State, ten times above the NHM’s mandated key performance indicator of below 2%.
      • Urban areas report a higher death percentage as they offer tertiary care, and admit several serious cases from peripheral districts.
      • The issue of under-reporting is illustrated by the NHM’s Child Health Review 2019-2020, which highlights 43 districts where government officials don’t report more than 50% of deaths of childern under 5, to falsely jack up their score.

      NATIONAL HEALTH MISSION

      The National Health Mission (NHM) was launched by the government of India in 2013 subsuming the National Rural Health Mission and National Urban Health Mission. It was further extended in March 2018, to continue until March 2020. It is headed by Mission Director and monitored by National Level Monitors appointed by Government of India

      The major programmatic components include Health System Strengthening, Reproductive-Maternal- Neonatal-Child and Adolescent Health (RMNCH+A), and Communicable and Non-Communicable Diseases.

      PROGRESS SO FAR UNDER NHM
      • Since the launch of the NRHM/NHM, a faster retardation has been noticed in the Maternal Mortality Ratio (MMR), Under Five Mortality Rate (U5MR) and the IMR
        • As per the current rate of decline, India is expected to reach its SDG target (MMR-70, U5MR-25) earlier than its due year i.e. 2030.
      • With respect to bringing down the Malaria cases and deaths, India has emerged as the biggest success story amongst Malaria endemic countries in the World by reducing the deaths due to Malaria by 49.09% and 50.52% in 2013 respectively as compared to 2017.
      • Strengthening and further intensification of the Revised National Tuberculosis Control Programme (RNTCP) has been done. Around 1,180 Cartridge-based nucleic acid amplification test (CBNAAT)  machines have been installed across all districts which provides rapid and accurate diagnosis for TB including drug resistant TB. 
      • Due to these intensified efforts, there is 16% rise in identification of new cases in a single year. 
      • Universal drug sensitive cases has also increased by 54%. 
      • Newer drug regimen of Bedaquiline and Delaminide and a nutrition support for all the TB patients for the duration of the treatment has been rolled throughout the country.
      • Tetanus and adult Diphtheria (Td) vaccine replaced Tetanus Toxoid (TT) vaccine amongst the new vaccines, under universal immunization programme in 2018 that ensure Diphtheria immunity among adults.
      • Further, Measles-Rubella (MR) vaccination drive was conducted in 2018 across 17 additional States, which further covers 30.50 Crores children till March 2019.
      • According to the latest updates, all the States/UTs are covered with Rotavirus vaccine (RVV).
      • Pneumococcal Conjugated Vaccine (PCV) was further expanded to MPHaryana and the remaining districts of BiharRajasthan and Uttar Pradesh during 2018-19. 
      • The routine and recurring incentives which are provided to ASHAs  increased from 1000 per month to 2000 per month.
      • A cover of Pradhan Mantri Jevan Jyoti Beema Yojna (a premium of Rs. 330 contributed by Gol) and Pradhan Mantri Suraksha Beema Yojna (a premium of Rs.12 contributed by Gol) was provided to ASHAs and ASHA Facilitators.
      • In April 2018, Anaemia Mukt Bharat (AMB) Abhiyaan was launched under POSHAN Abhiyaan.
      • There has been an increment in the untied funds amount from Rs, 20,000 to Rs 50,000 for sub health Centres transformed to HWCs.
      • Also, the Home Based Care for Young Child (HBYC) programme was introduced under POSHAN Abhiyaan.
      • The scheme was approved for awarding States/UTs/Districts for achieving disease free status in TB/Leprosy/Malaria/Kala-Azar/Lymphatic-Filariasis/Cataract.  
      • Also, approval was given to the National Viral Hepatitis Control Programme that aided in the prevention, management and treatment of Hepatitis A, B, C and E.


      KASHI EK ROOP ANEK: ONE DISTRICT ONE PRODUCT

      Context: PM Modi participates in ‘Kashi Ek Roop Anek’ event held at Deen Dayal Upadhyay Trade Facilitation Center Varanasi, Uttar Pradesh.


      KASHI EK ROOP ANEK



      WHAT IS IT?:  ‘Kashi Ek Roop Anek’, is basically a cultural arts and handicrafts exhibition held in Varanasi, Uttar Pradesh.


      ‘Kashi Ek Roop Anek’ showcased products from over 10,000 artisans from all over Uttar Pradesh. There are 23 lakh artisans and weavers that resides in Uttar Pradesh. Out of these, about 35,800 artisans and 1.5 lakh weavers stay in Varanasi alone

      Earlier, the Uttar Pradesh government had launched the ambitious scheme ‘One District, One Product’ (ODOP) in which one craft per district was identified. The state government has established raw material banks, testing labs, common facility centres, and facilitated direct market access to artisans and weavers and helping them improve their income.

      PM Modi not only inspected the stall of HandloomPink MeenakariWooden ToysChandauli Black RiceKannauj’s PerfumeMoradabad’s Metal CraftsAgra Leather ShoesLucknow’s Chikankari, and Azamgarh Black Pottery under the One District One Product but also interacted with artisans and craftsman. He also distributed kits and financial assistance to artisans and craftsman from different crafts.

      WHAT IS ‘ONE DISTRICT, ONE PRODUCT’ SCHEME OF U.P. GOVERNMENT?

      The UP government’s One District, One Product Programme aims to encourage such indigenous and specialized products and crafts. 


      MISSION: One District One Product Programme is aimed at creating product-specific traditional industrial hubs across 75 districts of Uttar Pradesh that will promote traditional industries that are synonymous with the respective districts of the state.

      There are products in UP that are found nowhere else – like the ancient and nutritious ‘Kala namak’ rice, the rare and intriguing wheat-stalk craftworld-famous chikankari and zari-zardozi work on clothes, and the intricate and stunning horn and bone work that uses the remains of dead animals rather than live ones, a nature-friendly replacement for ivory.

      LIST OF DISTRICT WISE PRODUCTS

      • Agra: Leather Products

      • Aligarh: Locks and Hardware

      • Ambedkar Nagar: Textile Products

      • Amethi: Moonj Products

      • Amroha: Musical Instruments

      • Auraiya: Food Processing (Desi Ghee)

      • Ayodhya: Jaggery

      • Azamgarh: Black Pottery

      • Baghpat: Home Furnishing

      • Bahraich: Wheat-Stalk Handicrafts

      • Ballia: Bindi (Tikuli)

      • Balrampur: Food Processing (Pulses)

      • Banda: Shazar Stone Craft

      • Barabanki: Textile Products

      • Bareilly: Zari-Zardozi

      • Basti: Wood Craft

      • Bhadohi: Carpet (Dari)

      • Bijnor: Wood Craft

      • Budaun: Zari-Zardozi

      • Bulandshahar: Ceramic Product

      • Chandauli: Zari-Zardozi

      • Chitrakoot: Wooden Toys

      • Deoria: Decorative Products

      • Etawah: Textile Products

      • Etah: Ankle Bells (Ghungroo), Bells and Brass Products

      • Farrukhabad: Textile Printing

      • Fatehpur: Bedsheets and Iron Fabrication Works

      • Firozabad: Glassware

      • Gautam Buddh Nagar: Readymade Garments

      • Ghazipur: Jute Wall Hanging

      • Ghaziabad: Engineering Goods

      • Gonda: Food Processing (Pulses)

      • Gorakhpur: Terracota

      • Hamirpur: Shoes

      • Hapur: Home Furnishing

      • Hardoi: Handloom

      • Hathras: Hing Asafoetida

      • Jalaun: Handmade Paper Art

      • Jaunpur: Woollen Carpets (Dari)

      • Jhansi: Soft Toys

      • Kannauj: Perfume (Attar)

      • Kanpur Dehat: Aluminum Utensils

      • Kanpur Nagar: Leather Products

      • Kasganj: Zari Zardozi

      • Kaushambi: Food Processing (Banana)

      • Kushinagar: Banana Fiber Products

      • Lakhimpur Kheri: Tribal Craft

      • Lalitpur: Zari Silk Sarees

      • Lucknow: Chikankari & Zari Zardozi

      • Maharajganj: Furniture

      • Mahoba: Gaura Stone Craft

      • Mainpuri: Tarkashi Art

      • Mathura: Sanitary Fittings

      • Mau: Powerloom Textile

      • Meerut: Sports Products

      • Mirzapur: Carpets

      • Moradabad: Metal Craft

      • Muzaffarnagar: Jaggery

      • Pilibhit: Flute

      • Pratapgarh: Aamla Products

      • Prayagraj: Moonj Products

      • Raebareli: Wood Work

      • Rampur: Applique Work along with Patch Work, Zari Patchwork

      • Saharanpur: Wood Crafting

      • Sambhal: Handicraft (Horn-Bone)

      • Sant Kabir Nagar: Brassware Craft

      • Shahjahanpur: Zari Zardozi

      • Shamli: Iron Arts

      • Shravasti: Tribal Craft

      • Siddharthnagar: Kala Namak Rice

      • Sitapur: Carpet (Dari)

      • Sonbhadra: Carpets

      • Sultanpur: Moonj Products

      • Unnao: Zari Zardozi

      • Varanasi: Banarasi Silk Saree


      (adsbygoogle = window.adsbygoogle || []).push({});

      Follow us on:


      Join us on Telegram: http://t.me/ExamGuideUpsc

      mbtTOC();

      Leave a Reply

      Your email address will not be published. Required fields are marked *